News

Boston Scientific Rendering

Boston Scientific Moves Forward with Minnesota Expansion Plans

Finance & Commerce reports that Boston Scientific is moving forward with a major expansion in Maple Grove, Minnesota.

The Maple Grove Planning Commission has given its backing to a proposed building expansion at the company’s Weaver Lake Road campus. The project will add 84,000 square feet of manufacturing and support space to the existing 86,000-square-foot facility.

The Commission recommended approval of the planned development stage on Monday evening. According to Peter Vickerman, Maple Grove’s planning manager, the City Council is set to make a decision on the expansion approval by December 2. If approved, construction is expected to begin in early 2025.

The new building will be located on an existing parking lot, and the expansion will occur in two phases.

This expansion is part of Boston Scientific’s “Project Black Bear,” a confidential initiative that was only identified as the company’s by Finance & Commerce last summer. The project involves a $170 million investment to create a new divisional headquarters campus.

The company plans to relocate employees from its peripheral interventions, interventional cardiology therapies, Watchman, and urology divisions from both Maple Grove and Minnetonka to the new campus. A spokesperson told MassDevice in mid-2023 that the expansion is expected to create 177 new jobs, with an average hourly wage of $65.

Boston Scientific is already the largest employer in Maple Grove, with approximately 4,000 workers in the city. The company has been steadily expanding its four-building campus near Interstate 94 and Weaver Lake Road in recent years.

Source: Finance & Commerce

Post a comment

Your email address will not be published. Required fields are marked *

Recent News

Relevance Ventures Leads Multimillion-Dollar Series B Financing for Aqua Medical to Advance Minimally Invasive Type 2 Diabetes Treatment

The Growth of the Medical Industry Amid Tariff Pressures and the Push to Reshore Manufacturing to the United States

Vent Creativity℠ Obtains FDA-Clearance for AI-Powered Digital-Twin Knee Arthroplasty Planning Tool, Hermes.

Johnson & Johnson MedTech Announces Approval of MONARCH™ QUEST for Enhanced Robotic-Assisted Bronchoscopy

Globus Medical obtains FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System

Successful completion of the inaugural shoulder arthroplasty surgeries utilizing Stryker’s Blueprint® Mixed Reality Guidance System occurred at Mayo Clinic in Minnesota and St. Joseph’s Health Care in London, Canada.

Medical Device Technologies Market is projected to increase from USD 4.20 Billion in 2022 to USD 16.32 Billion by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 18.50% over the forecast period

Hodess Cleanroom Construction expands its cleanroom services capabilities with the acquisitions of Protocol Management Services and Clean Rooms West

Medtronic Will Invest Up to $75 Million And begin Co-Promotion For CathWorks’ FFRangio System In The U.S. Europe and Japan

Tornier Shoulder Arthroplasty Portfolio Introduced by Stryker, With New Tornier Perform Humeral System Launched in Europe